BiPar Sciences, Inc.
BiPar Sciences, Inc., a pioneering biotechnology firm headquartered in the United States, has established itself as a leader in the development of innovative cancer therapies. Founded in 2001, the company has made significant strides in the oncology sector, focusing on targeted treatments that enhance patient outcomes.
With a strong presence in major operational regions across North America, BiPar Sciences is renowned for its unique approach to drug development, particularly in the realm of personalised medicine. The company’s core products, including its proprietary compounds, are distinguished by their ability to selectively target cancer cells while minimising side effects.
BiPar Sciences has garnered recognition for its commitment to advancing cancer care, positioning itself as a key player in the biotechnology industry. Its notable achievements reflect a dedication to scientific excellence and a passion for improving the lives of patients battling cancer.
+62 vs industry average
BiPar Sciences, Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at BiPar Sciences, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for BiPar Sciences, Inc. yet.
BiPar Sciences, Inc.'s reported carbon emissions
BiPar Sciences, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sanofi, and as such, it inherits emissions data and climate commitments from its parent organisation.
While no direct emissions figures are provided, BiPar Sciences is aligned with Sanofi's sustainability initiatives, which include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative. These commitments reflect a broader corporate strategy aimed at reducing carbon emissions across various scopes, including Scope 1, 2, and 3 emissions.
As a subsidiary, BiPar Sciences benefits from Sanofi's established climate targets and reduction initiatives, although specific targets or achievements for BiPar Sciences itself have not been disclosed. The company is expected to contribute to the overarching goals set by Sanofi, which are designed to enhance sustainability and reduce the environmental impact of its operations.
In summary, while BiPar Sciences, Inc. does not currently report specific emissions data or reduction targets, it is positioned within a corporate framework that prioritises climate action and sustainability through its relationship with Sanofi.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
BiPar Sciences, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for BiPar Sciences, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project